BAZ2-ICR is primarily utilized in the field of epigenetics and cancer research due to its role as a selective inhibitor of BAZ2A and BAZ2B bromodomains. These bromodomains are involved in chromatin remodeling and gene regulation, making BAZ2-ICR a valuable tool for studying their biological functions. Researchers use it to investigate the impact of BAZ2A/B inhibition on cancer cell proliferation, as these proteins are often overexpressed in certain cancers. Additionally, BAZ2-ICR helps in understanding the mechanisms of transcriptional regulation and chromatin dynamics, providing insights into potential therapeutic targets for diseases linked to epigenetic dysregulation. Its application extends to drug discovery, where it serves as a lead compound for developing more potent and specific inhibitors targeting BAZ2A/B-related pathways.